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Isatin thiosemicarbazone-blended polymer films for biomedical 
applications: surface morphology, characterisation and preliminary 
biological assessment 
David Mallinsona+, Polyxeni Alexioub+, Alexander B. Mullena, Maria Pelecanoub, Marina 
Sagnoub*, Dimitrios A. Lamprouac* 
Poly (methyl methacrylate) and polyurethane are polymers currently used for a range of biomedical applications. To modify 
their surface characteristics, biocompatibility and potentially reduce any related side effects the addition to the polymers of 
appropriate compounds has been investigated. Isatin thiosemicarbazone derivatives were synthesised and added to poly 
(methyl methacrylate) and polyurethane solutions before spin coating them on to a silica wafer. The resultant films were 
characterised with contact angle goniometry and atomic force microscopy. PMMA films produced from tetrahydrofuran 
solvent displayed honeycombed structures which were highly hydrophobic; however, such changes were not seen for 
polyurethane surfaces. The cytotoxicity and effect on cell proliferation of polymer surfaces were investigated using PNT2A 
prostate cells. The isatin-containing polymers were deemed non-toxic at the concentrations used, while cell proliferation 
studies suggested that the resulting films were supportive of cell growth.
Introduction 
Implantable medical devices have revolutionised the practice of 
modern medicine. However, stenting procedures are often 
accompanied by undesirable side effects such as encrustation, 
inflammation and bacterial adhesion1. Some of these 
phenomena are closely related to the ability of proteins to be 
directly adsorbed onto the stent surface. In the case of ureteral 
devices, for example, the most common problems associated 
with indwelling are encrustation, bacterial adhesion and biofilm 
formation on the device surface. Encrustation is often 
associated with infection by urease-producing bacteria such as 
Proteus mirabilis and some Klebsiella species leading to increase 
in urinary pH, an environment that favours bacterial growth and 
mineral crystallisation2 ? DŽƌĞŽǀĞƌ ? ĂŶ ŝŵƉůĂŶƚ ?Ɛ  ƐƵƌĨĂĐĞ
characteristics, such as hydrophobicity, roughness, porosity and 
chemical composition, have direct influence on the protein and 
bacterial adsorption and are closely associated  with a variety of 
adverse reactions, including inflammation, fibrosis, thrombosis 
and infection3. In order to make medical implants safer, 
increase their biocompatibility and stave off side effects, 
coating with a variety of materials, ranging from diamond-like 
carbon4 to heparin5 and polymers, have been introduced.  
Polymers, such as poly(lactic-co-glycolic acid) (PLGA)4, are 
employed as coatings for metal stents providing both the 
strength and durability of the metal skeleton and the tunable 
properties of the polymer. 
Biocompatibility improvement can be achieved by introducing 
regular patterns on the implant surface with ordered 
morphologies and controllable sizes5. Several polymers are 
already being used in biomedical settings such as polyurethane 
(PU) for ureteral catheters2, poly (methyl methacrylate) 
(PMMA)6 for bone glue and polytetrafluoroethylene (PTFE) for 
vascular grafts7 or hernia repair8. Most of the reported studies 
ƌĞůǇ ŽŶ ŶĞĂƚ ƉŽůǇŵĞƌ ŵŽůĞĐƵůĞƐ ? ŚŽǁĞǀĞƌ ? ďǇ  ‘ďůĞŶĚŝŶŐ ? ŝŶ
pharmacologically active compounds into the polymers, surface 
modifications might be achieved affecting not only the 
biocompatibility, chemical or structural properties but also 
pathogen susceptibility, cell growth and cell metabolism.  
Isatin (1H-indole-2,3-dione) and its derivatives have sparked 
great attention in recent years due to their wide variety of 
biological activities. Isatin was first discovered as a product of 
indigo oxidation9, and has been recognised as an endogenous 
human biomolecule as found to be an adrenaline metabolite. It 
is evident from the literature that isatin derivatives are 
associated with a diverse range of biological activities including  
anti-inflammatory10, 11, anti-nociceptive12, antibacterial13-20, 
antifouling21, antiviral22, and anticorrosion23. Despite this broad 
spectrum of activities, little research has been performed on 
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their incorporation into biomaterials. Tahermansouri and 
Chitgar24 included an isatin derivative in a carbon nanotube 
creating a material that was highly toxic to gastric and colonic 
cancer cells. 
It was therefore of interest to study the effect of two new isatin 
derivatives 1 and 2 (Fig 1) on the generation of PU and PMMA 
surfaces. Both derivatives share the common feature of the 
phenyl thiosemicarbazone moiety which is characterised by 
extensive electron delocalisation and it may exist in a 
tautomeric form, the thione and the thiol form.  The 5-position 
of the isatin core bears an electron withdrawing substituent, 
either the highly polarisable nitro group (derivative 1) or the 
more compact fluorine atom (derivative 2).  Derivative 1 has 
previously been investigated by Pervez et al.25, showing some 
antileishmanial activity. Ali et al.26, 27 has investigated the 
derivatives resemble compounds for 
anticancer/antiproliferative activities. They found that the 
presence of a fluorine in the position it is in derivative 2 above 
lowered the IC50 values for cytotoxicity against HCT 116 cells. 
These compounds were not necessarily chosen for their 
demonstrated activities since they are similar to structures that 
are biologically active. In the current study, derivative 2 the 
isatin NH functionality has been alkylated depriving the 
molecule of its capacity to hydrogen bond through this site.  The 
PU and PMMA surfaces developed after blending in derivatives 
1 and 2 were characterised by contact angle goniometry (CAG) 





Poly (methyl methacrylate) (PMMA; MW 94,600 g mol-1) was 
purchased from Acros Organics and polyurethane (PU) from 
Fluka. Tetrahydrofuran (THF), toluene, ethylene glycol (EG), 
diiodomethane (DIM), RPMI 1640 cell culture media, L-
glutamine, trypan blue and foetal bovine serum (FBS) from 
Sigma. Kanamycin sulphate and trypsin-EDTA from Life 
Technologies. RPMI 1640 complete media was made from L-
glutamine (1 % v/v), kanamycin sulphate (1 % v/v) and foetal 
bovine serum (10 % v/v) in RPMI-1640 media. Unless otherwise 
stated, all reagents and solvents for the synthesis stage were 
obtained from Alfa Aesar or ChemBiotin and used without 
further purification.  
Of the solvents used in this study, THF has a greater vapour 
pressure (19.3 kPa) than toluene (3.8 kPa), with the boiling point 
of THF (66 °C) being far lower than for toluene (111 °C). 
Moreover, THF is more hydrophilic than toluene (logP values of 
0.46 and 2.73, respectively), with the density of the solvents 
being approximately identical for THF (0.88 g cm-3) and toluene 
(0.86 g cm-3). This information will help the reader to 
understand the different structures on the produced isatin-
polymer blended surfaces.  
 
Isatin derivative synthesis 
Air sensitive chemical synthesis was performed in dry and inert 
conditions under a nitrogen atmosphere. All reactions were 
routinely checked by Thin-layer chromatography (TLC) on Silica 
gel Merck 60 F254 and compounds were purified by column 
chromatography on silica gel using the appropriate solvent 
systems or by preparative High-performance liquid 
chromatography (HPLC). The purity of the biological tested 
compounds was determined by an analytical HPLC method and 
was found to be greater than or equal to 95 %. The purity was 
determined automatically by MS parameters and was 
performed on a HPLC Shimadzu 2010EV (Column: Merck 
Purospher RP-C8, 250 x 4.6 mm, 5 µm particle size), equipped 
with a SPD-20A UV/Vis detector. Characterization of target 
compounds was established by a combination of ESI-MS and 
NMR spectrometry techniques. 1H and 13C NMR spectra were 
recorded on a Bruker Avance DRX spectrometer (500 MHz). 
ŚĞŵŝĐĂů ƐŚŝĨƚƐ ĂƌĞ ƉƌĞƐĞŶƚĞĚ ŝŶ ƉƉŵ  ?ɷ ? ǁŝƚŚ ŝŶƚĞƌŶĂů dD^
standard. MS were obtained by the mass detector of the already 
mentioned HPLC Shimadzu 2010EV. 
 
Isatin derivatives synthetic procedure 
The thiosemicarbazones were prepared by combining 
equimolar amounts of the commercially available substituted 
isatins (3.5 mmol) and thiosemicarbazide (3.5 mmol) dissolved 
in ethanol followed by the addition of a few drops (100-200 ȝL) 
of glacial acetic acid to initiate the reaction. The mixture was 
refluxed overnight and the corresponding thiosemicarbazone 
precipitated during the course of the reaction. All final 
compounds were recrystallized from DMSO with a small 
amount of water. 
Derivative 1 ((E)-2-(5-nitro-2-oxoindolin-3-ylidene)-N-
phenylhydrazinecarbothioamide): This was synthesised 
according to the general procedure by reacting 5-nitroisatin 
with 4-phenyl-3-thiosemicarbazide. Yield = 74%. 1H NMR 
(500Hz, DMSO-d6 ?ɷ ? ? ? ? ?  ?Ɛ ? ?, ? ? ? ? ? ? ?  ?Ɛ ? ?, ? ? ? ? ? ? ?  ?Ɛ ? ?, ? ?
8.71 (d, J = 2.0 Hz, 1H), 8.30 (dd, J = 8.7, 2.3 Hz, 1H), 7.60 (d, J = 
7.7 Hz, 2H), 7.47 (t, J = 7.8 Hz, 2H), 7.32 (t, J = 7.3 Hz, 1H), 7.15 
(d, J = 8.7 Hz, 1H);  13C NMR (125.5 MHz,  DMSO-d6 ? ?ɷ ? ? ? ? ? ? ?
163.05, 147.55, 142.81, 138.28, 130.34, 128.51, 127.11, 126.44, 
126.03, 120.94, 116.76, 111.28; ESI-MS (m/z) [M+H]+ calculated 
for [C15H12N5O3S+] 342.07 Found: 342.15, HPLC analysis: peak 
area = 95.770 %, Mobile Phase A: aq. CH3COONH4 10 mM, 
pH=3.9 with formic acid; Mobile Phase B: MeOH; Detected at 
255 nm. 
Fig. 1 Isatin and the thiosemicarbazone derivatives. 
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Derivative 2 ((E)-2-(5-fluoro-2-oxo-1-(piperidin-1-
ylmethyl)indolin-3-ylidene)-N-
phenylhydrazinecarbothioamide): This was synthesised in two 
steps. 5-fluoroisatin initially reacted with 4-phenyl-3-
thiosemicarbazide according to the general procedure. To a 
suspension of the resulting (E)-2-(5-fluoro-2-oxoindolin-3-
ylidene)-N-phenylhydrazinecarbothioamide (2 mmol) in 
absolute ethanol, 37 % formaldehyde solution and piperidine (2 
mmol) were subsequently added dropwise with vigorous 
stirring. After combining all reagents, the reaction mixture was 
stirred at 500 rpm at room temperature for 10 h. The solid 
product was filtered and washed with petroleum ether. Yield 
(for the two steps) = 61 %. 1H NMR (500Hz, DMSO-d6 ?ɷ ? ? ? ? ?
(s, 1H), 10.89 (s, 1H), 7.70 (d, J = 8.0 Hz, 1H), 7.62 (d, J = 7.6 Hz, 
2H), 7.45 (t, J = 7.8 Hz, 2H), 7.32  ? 7.28 (m, 3H), 4.50 (s, 2H), 2.56 
 ? 2.53 (m, 4H), 1.53  ? 1.42 (m, 4H), 1.39  ? 1.29 (m, 2H).;  13C 
NMR (125.5 MHz,  DMSO-d6,) 176.28, 161.75, 159.57, 157.68, 
140.21, 138.25, 128.45, 126.25, 125.61, 120.74, 120.66, 117.45, 
117.26, 112.57, 112.51, 108.02, 107.81 , 62.10, 51.30, 25.33, 
23.53.; ESI-MS (m/z)[M+H]+ calculated for [C21H23FN5OS+] 
412.16 Found: 412.21, HPLC analysis: peak area = 96.765 %, 
Mobile Phase A: aq. CH3COONH4 10 mM, pH=3.9 with formic 
acid; Mobile Phase B: MeOH; Detected at 255 nm. 
 
Spin Coating 
Polymers used as purchased from the suppliers and not 
prepared from monomers. Polymer solutions were made with 2 
% w/v poly (methyl methacrylate) PMMA or polyurethane (PU) 
in tetrahydrofuran (THF) or toluene by leaving it overnight in a 
sealed glass vial in order to be dissolved. Isatin derivative 
solution (dissolved in THF to 10 mg mL-1) was added to the 
polymer solution to provide the following preparations where 
isatin derivatives are used at 10 µM unless otherwise stated 
(Table 1). Silica wafer (SW) was cut into 100-200 mm2 pieces and 
cleaned with 70 % v/v ethanol and finally with the solvent that 
was used in individual polymer solutions. Solutions were 
applied to silica wafer and spun at 2000 rpm for 30 s with a 
Laurell WS-400-6NPP spin coater. Humidity was measured by 
placing an Exoterra digital hygrometer within the spin coater on 
a dry run. Experiments were repeated at least 3 times on 
different surfaces. 
 
Table 1 Naming of the surfaces according to isatin derivative, solvent and polymer. 
Derivatives used at 10 µM except for surface I which was used at 50 µM to investigate 
the effect of a higher concentration. 
Derivative None Derivative 1 Derivative 2 
Polymer PMMA PU PMMA PU PMMA PU 
THF A B E, I F J K 
Toluene C D G H L M 
 
Contact Angle Goniometry (CAG) 
Surface ĞŶĞƌŐǇ ?ɶs) and their components, were determined by 
measuring the contact angles of three solvents on surfaces. 
Briefly, the contact angle of drops of deionised water (DW; 18.2 
Dɏ ?ɶL 72.8 mN m-1 at 20 ° ? ?ĚŝŝŽĚŽŵĞƚŚĂŶĞ ?/D ?ɶL 50.8 mN 
m-1 at 20 °C) and 1,2-ĞƚŚĂŶĞĚŝŽů  ?ĞƚŚǇůĞŶĞŐůǇĐŽů ?  ?' ?ɶL 48.0 
mN m-1 at 20 ° ? ?ƐƵƌĨĂĐĞƚĞŶƐŝŽŶɶL values from Lamprou et al. 
28) on surfaces were measured with a Krüss DSA30B contact 
ĂŶŐůĞ ŐŽŶŝŽŵĞƚĞƌ ? ĚǀĂŶĐŝŶŐ ĂŶŐůĞƐ  ?ɽA) were obtained from 
both the left and right side of each drop at 10-20 s after drop 
ƉůĂĐĞŵĞŶƚ ?^ƵďƐƚƌĂƚĞƐƵƌĨĂĐĞĞŶĞƌŐŝĞƐ ?ɶs) were then calculated 
from the mean contact angles using the Good and Oss 3-liquid 
formula 29 via an in-house Visual  Basic program 28. 
 
Atomic Force Microscopy (AFM) 
AFM was performed with a Bruker Multimode 8 atomic force 
microscope with a Nanoscope V controller in ambient 
conditions in air. ScanAsyst Air probes (Bruker) with V-shaped 
silicon nitride cantilevers with nominal spring constants of 0.4 
Nm-1 were used. Peak force quantitative nanomechanical 
mapping mode was used in air in order to scan the surface with 
a resolution of 512 samples per line and scan rate of 1 Hz. 
Roughness (Ra) data was calculated using Nanoscope Analysis 
on five images at scan size 5 × 5 µm. 
 
Cytotoxicity and cell proliferation studies 
PNT2A cells (prostate cells) were grown in RPMI complete 
media. Cells were grown at 37 °C in a 5 % CO2 atmosphere and 
split when they reached 70-80 % confluence. For the 
cytotoxicity studies isatin derivatives were tested in solution. 
They were dissolved in THF (10 mg mL-1) then diluted further in 
media and compared against solvent (THF), and media-only 
controls by means of an Alamar blue (resazurin) assay. The 
initial solutions were clearly homogeneous after dilution with 
media, without any precipitation during the incubation as 
experiments took place at 37 °C which helps increase the 
solubility without losing THF. Resazurin is converted to 
fluorescent resorufin by cells such as the fluorescence can be 
indicative of metabolic rate and cell population. Fluorescence 
was read with a SpectraMax M5 (Molecular Devices) with 
excitation at 560 nm and emission at 590 nm. For proliferation 
on surfaces cells were grown on sample surfaces at the bottom 
of a 24-well cell culture plate for in triplicate with an empty 
 ?ƉŽůǇƐƚǇƌĞŶĞ ?ǁĞůůĂƐĂĐŽŶƚƌŽů ?ĨƚĞƌ ?ĚĂǇƐ ?ĐĞůůŐƌŽǁƚŚ ?ƚŚĞĐĞůů
media was replaced with resazurin-cell media solution and 
incubated for 24 h. Then two aliquots were taken of each well 
and fluorescence measured as before. 
 
Statistical Analysis 
Significances for contact angles (Table 2) were found through 
two-ƐĂŵƉůĞ^ƚƵĚĞŶƚ ?ƐƵŶƉĂŝƌĞĚd-tests for each pair of samples 
within each solvent. Significances for cytotoxicity (Fig. 5) were 
calculated with two-sampůĞ^ ƚƵĚĞŶƚ ?ƐƵŶƉĂŝƌĞĚd-tests between 
ĞĂĐŚ ĐŽŶĐĞŶƚƌĂƚŝŽŶ ?Ɛ ƐĂŵƉůĞ ĂŶĚ ŝƚƐ ƐŽůǀĞŶƚ-only equivalent 
control. Significances for cell proliferation (Fig. 6) were 
calculated with two-ƐĂŵƉůĞ^ ƚƵĚĞŶƚ ?ƐƵŶƉĂŝƌĞĚd-tests between 
each surface and the control surface. Significance tests were 
performed in Minitab 17. The significance level chosen was 
0.05. 
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Results and discussion 
Synthesis 
Both derivatives 1 and 2 were successfully prepared in high yield 
by treating the corresponding 5-substituted isatin moiety with 
phenyl thiosemicarbazide. The desired products precipitated 
out of the reaction mixture in high purity. The products are 
soluble in most organic solvents and give stable solutions.  
Based on the general structural characteristics of the two 
derivatives, it is anticipated that the polar THF solvent would 
interact more with the NH- group, the nitro-related local charge 
and potentially stabilise the thiol tautomeric form of derivative 
1. This could create areas of repulsion leading to a more ordered 
arrangement. On the contrary, this cannot be feasible for 
derivative 2 due to lack of the free NH- moiety and the different 
electronic effect of the 5-fluoro group. With regards to toluene, 
it could not promote any favourable arrangement for the two 
derivatives. With the given experimental conditions, the 
compounds should not interact in any direct way with the 
polymers. 
 
Contact Angle Goniometry 
Table 2 Advancing contact angles (ɽA) of the probe liquids (deionised water (DW), 
ethylene glycol (EG) and diiodomethane (DIM)) on the surfaces (n = 6) as in Table 1. 
 
Table 3 ^ƵƌĨĂĐĞ ĞŶĞƌŐŝĞƐ  ?ɶs) and their components as determined by CAG, and AFM 
surface roughness (Ra) values. Surfaces are as described in Table 1. 
 
ĚǀĂŶĐŝŶŐ ĐŽŶƚĂĐƚ ĂŶŐůĞƐ  ?ɽA) of the probe liquids on the 
surfaces with and without the isatin derivatives are presented 
in Table 2. Both compounds cause a significant increase in 
surface hydrophobicity, as highlighted by the increased water 
contact angles in the case of the THF/PMMA surfaces (from 
77.3° to 118.8° for surfaces A and E). An angle of 118.8 ± 0.7° 
was observed for the addition of derivative 1 in 2 % w/v PMMA 
in THF (surface E). The lower surface energy values (Table 3) 
correlate well with high water contact angle values. The 
roughness values (Table 3) also correlate well with the water 
contact angle values (Table 2) as high roughness can correspond 
to high water contact angle as seen with the lotus effect30 
where air pockets remain under the drop giving rise to super-
hydrophobicity. The AFM images of surfaces E (Fig. 3) and J (Fig. 
4) show that they are rough with space for air pockets. It is 
likely, however, that the hydrophobicity would not persist once 
the air pockets collapse. There is a large difference in 
hydrophobicity between the PMMA-only surfaces (surfaces A 
and C) and those where an isatin derivative has been added to 
PMMA (surfaces E and J), which is associated with a large 
difference in surface roughness (Ra) (p < 0.01). It should be 
highlighted at this point that rougher surfaces can be favourable 
towards cell proliferation or osseointegration31, 32. 
  
Atomic Force Microscopy 
The AFM images of the surfaces generated from PMMA or PU 
solutions in the absence of isatin derivatives 1 and 2 are shown 
in Fig. 2, while the images of the surfaces in the presence of 1 
and 2 are given in Figs 3 and 4 respectively. Honeycombed 
structures were formed in both polymers (PMMA and PU) in the 
case of THF, but not in the presence of toluene as solvent. 
Toluene surfaces (Figs. 2B&D, 3B&D, 4B&D) are flat in 
comparison with the THF ones. The height scales in Fig. 3B and 
Fig. 3D are 6 nm and 12 nm respectively, while the pores in 
surface E (Fig. 3A) are 64.4 ± 7.3 nm deep and 312.8 ± 69.8 nm 
in diameter. 
The presence of isatin derivatives and the use of THF as a 
solvent appear to have an important influence on the formation 
of pores. By shifting the morphology from a smooth surface (A; 
Ra = 1.6 ± 0.7 nm) to rough surface with a honeycomb structure 
Surface 
ĚǀĂŶĐŝŶŐĐŽŶƚĂĐƚĂŶŐůĞƐ ?ɽA) /  Ț 
DW EG DIM  
A 77.3 ± 0.5 54.0 ± 2.5 40.7 ± 1.1 
B 85.1 ± 1.1 57.9 ± 2.7 42.1 ± 7.5 
C 66.5 ± 6.6 56.0 ± 1.6 38.5 ± 1.0 
D 72.2  ± 1.6 46.1 ± 6.6 49.7 ± 2.3 
E 118.8 ± 0.7 96.5 ± 2.7 73.0 ± 5.4 
F 88.8 ± 1.8 63.9 ± 2.2 34.9 ± 1.6 
J 109.6 ± 6.2 86.4 ± 8.3 69.7 ± 13.3 
K 90.8 ± 1.7 70.5 ± 2.9 33.2 ± 1.3 










Ra  by AFM / 
nm 
A 0.00 8.77 39.26 39.48 1.88 ± 0.33 
B 0.01 4.02 38.54 38.86 19.66 ± 2.75 
C 0.23 21.98 40.34 44.83 0.56 ± 0.18 
D 0.41 11.18 34.42 38.73 2.20 ± 0.64 
E 0.26 0.00 21.21 21.22 23.37 ± 0.99 
F 0.17 3.15 42.07 43.54 21.15 ± 1.91 
J 0.02 0.25 23.04 23.19 15.04 ± 1.02 
K 0.74 3.67 42.85 46.14 7.02 ± 0.66 
SW 0.33 22.36 38.49 43.92 0.15 ± 0.04 
Fig. 2 AFM height images of PMMA- or PU-only surfaces cast from toluene or THF. A) 
Surface A; B) surface C; C) surface B; D) surface D, as described in Table 1. Images are 5 
x 5 µm.
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(E; Ra = 23.4 ± 1.0 nm) led to an increase in hydrophobicity as 
indicated by the water contact angles and surface energies 
(Tables 2 & 3).  
The honeycombed structures imaged by AFM (Figs. 2-4) appear 
to be breath figure arrays (BFAs). BFAs are formed when water 
droplets act as a template around which a polymer is cast, as 
illustrated in Fig. 5. The droplets are formed by condensation on 
the solvent/air interface and can sink into the surface. As the 
solvent evaporates the temperature can fall to 0 °C which assists 
water condensation33. The droplets grow and their packing can 
become ordered. A hexagonal arrangement is optimal (seen as 
a honeycomb) but this can be compromised if droplets are too 
far apart to interact or coalesce. When all the solvent has 
evaporated the polymer will be cast in that position and the 
water can evaporate33. Spin coating tends to give smaller pores 
than dip coating or drop casting because a portion of the 
solution is lost at the beginning of the process and the solvent 
evaporates faster giving less time for the droplet to grow34.  
It is evident from the AFM images that the isatin derivatives 
have a clear effect on the topography of the generated surfaces.  
With THF as a solvent, they both produce pores that in the case 
of derivative 1 are much more prevalent and appear well 
ordered. Their specific effect on BFA formation is also 
demonstrated by the low relative humidity (RH 20-30% ambient 
conditions) under which they were formed, since in the absence 
of polymer doping formation of BFAs requires a humidity of 
above 50%29.  Jiang et al.30 reported that the addition of silver 
nanoparticles to polyurethane films allowed BFA formation in 
humidity conditions of 30% where they would not otherwise 
form.  Contamination of the THF as a solvent with water would 
also contribute to BFA formation as shown by Park and Kim35 
and by Jiang et al.36, however on its own would not explain the 
difference between the polymer-only surfaces (Fig. 2) and the 
derivative-doped surfaces (Fig. 3 & 4). Comparison with data 
ĨƌŽŵWĂƌŬĂŶĚ<ŝŵƐƵŐŐĞƐƚƐĂǁĂƚĞƌĐŽŶƚĞŶƚŽĨA䜀  ?A?ǀ ?ǀ35.   
The effect exerted by isatin derivatives may be related with 
their potential aggregation at the water/polymer surface 
forming a layer that stabilizes the condensed water droplets as 
has been suggested in the literature for silver30 and gold33, 
nanoparticles as well for self-organizing amphiphilic clusters34 
and self-associating organic molecules37. 
During the BFA process, the isatin derivatives may be prone to 
self-assembly as they possess multiple sites of intermolecular 
ŝŶƚĞƌĂĐƚŝŽŶ ƉŽƚĞŶƚŝĂů ƚŚƌŽƵŐŚ ŚǇĚƌŽŐĞŶ ďŽŶĚŝŶŐ ? ʋ-ʋ
interactions and dipolar interactions. Such a process may 
explain the more ordered surfaces generated in THF by 
derivative 1 compared to derivative 2 which lacks the indole NH 
functionality and the potential for hydrogen bonding through 
this site. The differential behaviour of the more polar THF 
compared to toluene may be also related with an overall 
stabilisation of a potential aggregation process.  Our continuing 
investigations on the conditions of generating new isatin-
blended polymers will hopefully provide more clues on the way 




Fig. 3 AFM height images of derivative 1-PMMA and PU surfaces made with THF 
or toluene. A) surface E; B) surface G; C) surface F; D) surface H, as described in 
Table 3. Images are 5 x 5 µm.
Fig. 4 AFM height images of derivative 2-PMMA and -PU surfaces made with 
THF or toluene. A) surface J; B) surface L; C) surface K; D) surface M, as described 
in Table 3. Images are 5 x 5 µm.
Fig. 5 Breath figure array formation process with particles (black dots). Water droplets 
nucleate and grow. The droplets partially sink in to the polymer surface acting as 
template while the solvent evaporates before evaporating themselves. 
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Cytotoxicity and Cell Proliferation 
The compounds do not appear to be cytotoxic in solution at the 
concentrations tested relative to controls (Fig. 6). This means 
that if the derivatives are released from the polymers will not 
be harmful in the human body. THF was required because the 
derivatives were not water soluble, therefore was tested as a 
control to see if it made any changes to cell survival.  
Cell proliferation data are presented in Fig. 7. Cells displayed 
significantly greater metabolic activity on the surface E 
(derivative 1; 10 µM PMMA; THF) which suggests that increased 
cell growth is supported in this case. Additionally, surface E 
supported cell proliferation better than the control surfaces 
(flat polystyrene). The beneficial effect of porous topography 
has previously been reported with fibroblasts grown on quartz 
(7-25 µm diameter pores)38, honeycombed polystyrene-
polypyrrole copolymer surfaces (~1 µm diameter) 39 and 
titanium (~6 µm diameter)40, and HeLa cells grown on poly(L-
lactide)-poly(L-lysine) copolymer surfaces (0.9 µm diameter 
pores)41. The above reported data reveal a tendency for smaller 
diameter pores to offer better cell proliferation. The pores in 
the current study have even smaller diameters (e.g. 312.8 ± 69.8 
nm in Fig. 3A) than the ones the authors are aware of being 
investigated for cell growth. The positive results for surface E in 
Fig. 7 support the idea that smaller pores can be supportive of 
cell growth. 
Though hydrophilic surfaces, such as chitosan, heparin and 
polyvinylpyrrolidone (PVP) are used antibacterial surfaces42, 
rough or hydrophobic surfaces have also been shown to be 
promising42, 43. While rough surfaces can be more prone to 
encrustation by plaque accumulation due to increased surface 
area for bacterial attachment44 their low surface energy can 
also repel bacteria42. This suggests that roughness and 
hydrophilicity alone are not the sole determining factors for the 
level of encrustation or bacterial attachment. 
Conclusion 
Despite the simple fast procedure of honeycomb film 
formation, several parameters can play a role in the honeycomb 
film morphology influencing for instance pore size or quality of 
ordering and cell growth. In this study, PU and PMMA films were 
prepared and isatin derivatives 1 and 2 were added to their 
solutions before spin coating on silica wafer in order to 
investigate the formation of honeycomb structures. The use of 
isatin thiosemicarbazone derivatives and tetrahydrofuran as a 
solvent was found to promote the formation of honeycombed 
structures by breath figure arrays which are known to improve 
biocompatibility and osseointegration. Cell proliferation studies 
have shown that the incorporation of derivative 1 into PMMA 
results in a honeycombed product with improved 
hydrophobicity that supports cell growth. In the current study, 
surface E significantly outperformed all other surfaces 
investigated in terms of cell proliferation which suggests that 
isatin derivative 1 incorporation into PMMA would be 
beneficial. In conclusion, the developed herein surfaces lend 
themselves to be used as biomaterials. 
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